Lanean...
Characterization of a rat model of bortezomib‐induced painful neuropathy
BACKGROUND AND PURPOSE: Bortezomib (Velcade®) is a breakthrough treatment for multiple myeloma, significantly improving patient survival. However, its use is limited by painful neuropathy often resulting in dose reduction/cessation of first‐line treatment due to lack of treatment. The aim of this st...
Gorde:
| Argitaratua izan da: | Br J Pharmacol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5727311/ https://ncbi.nlm.nih.gov/pubmed/28972650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14063 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|